Title : An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission.

Pub. Date : 2022 Feb 23

PMID : 35197485






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We developed a recombinant spike protein vaccine (called NARUVAX-C19) and characterized its ability when formulated with a nanoemulsion adjuvant to induce anti-spike antibody and T-cell responses and provide protection including against viral transmission in rodent. naruvax-c19 surface glycoprotein Severe acute respiratory syndrome coronavirus 2
2 We developed a recombinant spike protein vaccine (called NARUVAX-C19) and characterized its ability when formulated with a nanoemulsion adjuvant to induce anti-spike antibody and T-cell responses and provide protection including against viral transmission in rodent. naruvax-c19 surface glycoprotein Severe acute respiratory syndrome coronavirus 2